Thymalin
Polypeptide complex from calf thymus. Russian-developed immune modulator related to but distinct from Thymosin Alpha-1.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
Geropharm / Khavinson lineage. Russian clinical literature reports use in immune restoration after surgery, infections, and aging-related immune decline. Mechanism overlaps with TA-1 but the specific peptide composition differs. Western clinical evidence near zero.
Russian-academy lineage. Western replication absent. Animal-tissue origin (TSE concerns). Counterfeit risk in grey-market sources.
Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
- DMechanistic / anecdotal
Thymalin — primary mechanism: polypeptide complex from calf thymus. russian-developed immune modulator related to but distinct from thymosin alpha-1.
1 supporting referencesVerified 5d ago
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Pre-filled with this compound's published dose range: 10-30 mg per cycle · daily IM, in 5-10 day cycles
Draw volume exceeds 100 units (1 mL). Either reduce dose or split into multiple injections.
Calculator is a discussion tool. Verify reconstitution + dosing with a qualified provider. Stack is not a prescription source. Use sterile technique and inspect every vial.
Approved in RU/CIS; not FDA-evaluated